Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Liabilities from Discontinued Operations (2022 - 2024)

Bio Essence has reported Liabilities from Discontinued Operations over the past 3 years, most recently at 1345640.0 for Q1 2024.

  • For Q1 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 1345640.0; the TTM value through Mar 2024 reached 1345640.0, changed N/A, while the annual FY2023 figure was 976889.0, 1343.05% up from the prior year.
  • Liabilities from Discontinued Operations for Q1 2024 was 1345640.0 at Bio Essence, up from 976889.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 1345640.0 in Q1 2024 and troughed at 67696.0 in Q4 2022.
  • A 3-year average of 796741.67 and a median of 976889.0 in 2023 define the central range for Liabilities from Discontinued Operations.
  • On a YoY basis, Liabilities from Discontinued Operations climbed as much as 1343.05% in 2023 and fell as far as 1343.05% in 2023.
  • Year by year, Liabilities from Discontinued Operations stood at 67696.0 in 2022, then skyrocketed by 1343.05% to 976889.0 in 2023, then soared by 37.75% to 1345640.0 in 2024.
  • Business Quant data shows Liabilities from Discontinued Operations for BIOE at 1345640.0 in Q1 2024, 976889.0 in Q4 2023, and 67696.0 in Q4 2022.